| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 02/10/2005 | WO2005012503A1 Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection |
| 02/10/2005 | WO2005012492A2 Human skin equivalents expressing exogenous polypeptides |
| 02/10/2005 | WO2005011714A1 Process for the selective withdrawal of bacterial strains adhering to intestinal mucosa through endoscopy |
| 02/10/2005 | WO2005011524A1 Three-dimentional tissue structure |
| 02/10/2005 | WO2005011400A1 Supplement preparation |
| 02/10/2005 | WO2004096245A3 Muscle derived cells (mdcs) for promoting and enhancing nerve repair and regeneration |
| 02/10/2005 | US20050034181 Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 02/10/2005 | US20050034177 Genetic modification of male germ cells for generation of transgenic species & genetic therapies |
| 02/10/2005 | US20050033414 Drug-eluting stent with multi-layer coatings |
| 02/10/2005 | US20050033059 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 02/10/2005 | US20050033017 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/10/2005 | US20050032731 Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection |
| 02/10/2005 | US20050032702 Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| 02/10/2005 | US20050032217 Transforming lymphocytes with vector comprising gene sequences which code cytolethal distending toxin (cdt), leukotoxins and heat shock protein and generating regulatory cell which can be used to treat and/or prevent transplant rejection, autoimmune and inflammatory diseases; immunotherapy |
| 02/10/2005 | US20050032216 Plasmid comprising antibody specific for cell surface membrane protein receptor (5T4) for use in tissue directed treatment of tumors; tissue targeted therapy |
| 02/10/2005 | US20050032214 Cell-specific expression/replication vector |
| 02/10/2005 | US20050032213 Expression vector comprising polynucleotide which codes conditionally-inducible oncogene operably linked to enhancer of a nestin intron for use in prevention and treatment of disease associated with cell loss and/or damage |
| 02/10/2005 | US20050032210 Generating modified neuronal cells directed for use in treatment of graft rejection, graft-versus-host, autoimmune and allergic diseases |
| 02/10/2005 | US20050032209 Regeneration and repair of neural tissue using postpartum-derived cells |
| 02/10/2005 | US20050032207 Method for isolating, culturing and differentiating intestinal stem cells for therapeutic use |
| 02/10/2005 | US20050032160 Cell-based therapies for diabetes mellitus and other glucose intolerant states |
| 02/10/2005 | US20050032044 Lipid and cryoprotectant; gene therapy |
| 02/10/2005 | US20050032036 Using drug resistant bacterial strains as tools for identifying bactericidal phage; preventing staphylococcus infection |
| 02/10/2005 | US20050031732 Animal feed containing probiotic Bacillus |
| 02/10/2005 | US20050031687 Enteric-coated proliposomal formulations for poorly water soluble drugs |
| 02/10/2005 | US20050031646 Immunogens; polysaccharide conjugate antigens derived from pathogenic bacterium conjugated to protein D from Haemophilus influenzae |
| 02/10/2005 | US20050031643 Microorganisms for therapy |
| 02/10/2005 | US20050031642 Clonal lentogenic oncolytic strain of Newcastle Disease Virus and hemaglutinin-neuraminidase (HN) gene |
| 02/10/2005 | US20050031618 Induction of tolerance by apoptotic and/or necrotic cells |
| 02/10/2005 | US20050031612 Cytotoxic t lymphocytes; human leukocyte antigen; non-hematopoietic cells; graft versus host disease |
| 02/10/2005 | US20050031609 Compositions for use in treating ige-associated disorders |
| 02/10/2005 | US20050031608 Modified alpha-neurotoxins as painkillers |
| 02/10/2005 | US20050031602 Composition with heart rate reducing properties |
| 02/10/2005 | US20050031601 Composition comprising a lactobacillus pentosus strain and uses thereof |
| 02/10/2005 | US20050031600 Cardiac function by mesenchymal stem cell transplantation |
| 02/10/2005 | US20050031599 Method of isolating retinal stem cells and inducing retinal stem cells to produce retinal cells; retinal stem cell and retinal cell culture systems may be used for toxicological assays, for isolating genes involved in retinal differentiation or for developing tumor cell lines |
| 02/10/2005 | US20050031598 Engineering three-dimensional tissue structures using differentiating embryonic stem cells |
| 02/10/2005 | US20050031595 Ex-vivo expanding a population of stem cells, while inhibiting differentiation of the stem cells using a transition metal compound that chelates copper such as tetraethylenepentamine |
| 02/10/2005 | US20050031594 Pharmaceutical composition for treatment of cancers |
| 02/10/2005 | US20050031591 Tumor-specific promotor and use thereof |
| 02/10/2005 | DE10333406A1 T-regulatorische-Zellen enthaltend Galectine zur Therapie und Diagnose von Erkrankungen T-regulatory cells containing galectins for the therapy and diagnosis of diseases |
| 02/10/2005 | DE10331957A1 Pharmarzeutischer Wirkstoff gegen Magengeschwüre Pharmarzeutischer drug for stomach ulcers |
| 02/10/2005 | DE10297513T5 In vitro Herstellung von dendritischen Zellen aus CD14+ Monocyten In vitro production of dendritic cells from CD14 + monocytes |
| 02/10/2005 | CA2793046A1 Method for the isolation and expansion of cardiac stem cells from biopsy |
| 02/10/2005 | CA2758178A1 Human skin equivalents expressing exogenous polypeptides |
| 02/10/2005 | CA2536120A1 Polymer encapsulation of adenoviruses |
| 02/10/2005 | CA2534378A1 Method for the isolation and expansion of cardiac stem cells from biopsy |
| 02/10/2005 | CA2534377A1 Method for immunotherapy of tumors |
| 02/10/2005 | CA2534356A1 Scaffold-free self-organized 3d synthetic tissue |
| 02/10/2005 | CA2532883A1 Supplement preparation |
| 02/10/2005 | CA2529954A1 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| 02/09/2005 | EP1504766A1 Drug- or gene-carrier composition having lowered hemagglutinin activity |
| 02/09/2005 | EP1504763A1 Traditional chinese pharmaceutical formulation for treatment of paradentosis, process for preparation and use thereof |
| 02/09/2005 | EP1504261A2 A t cell subpopulation regulating gut immunity |
| 02/09/2005 | EP1504107A1 Recombinant fowlpox virus |
| 02/09/2005 | EP1504088A2 Bacteriophages useful for therapy and prophylaxis of bacterial infections |
| 02/09/2005 | EP1504087A2 Bioartificial skin |
| 02/09/2005 | EP1504016A2 Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses |
| 02/09/2005 | EP1503819A1 System and method for forming a non-ablative cardiac conduction block |
| 02/09/2005 | EP1503806A1 Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer |
| 02/09/2005 | EP1503801A2 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 02/09/2005 | EP1503789A2 Vascularization enhanced graft constructs |
| 02/09/2005 | EP1503788A2 Treatment of alpha-galactosidase a deficiency |
| 02/09/2005 | EP1503787A1 Compositions and methods for diagnosis and treatment of cardiovascular disorders |
| 02/09/2005 | EP1503776A1 Method of enhancing biological activity of plant extracts |
| 02/09/2005 | EP1503770A1 Method for extended storage of blood and blood components |
| 02/09/2005 | EP1503716A1 System and method for treating cardiac arrhythmias with fibroblast cells |
| 02/09/2005 | EP1503652A2 Vascularization enhanced graft constructs |
| 02/09/2005 | EP1503629A1 Multicultural fermented yogurt |
| 02/09/2005 | EP1503625A1 Vascularization enhanced graft constructs |
| 02/09/2005 | EP1503623A2 Immune t-cell stimulation |
| 02/09/2005 | EP1244425B1 Method for producing a cosmetically applicable marine mud extract |
| 02/09/2005 | EP1109888A4 Enhanced submucosal tissue graft constructs |
| 02/09/2005 | EP1079772B1 Corporal tissue penile reconstruction |
| 02/09/2005 | EP1037659A4 Fibrinolytic inhibitor for sealant |
| 02/09/2005 | EP1023440B1 Enteric coated microgranules for stabilizing lactic acid bacteria |
| 02/09/2005 | CN1578670A Use of lactalapoprotein in prevention and treatment of microbial or virus infection |
| 02/09/2005 | CN1578647A Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues |
| 02/09/2005 | CN1575819A Use of melanoma differentiation associated gene (mda-7) for reversing cancerous phenotype |
| 02/09/2005 | CN1575802A Composition for suppressing blood sugar ascending |
| 02/09/2005 | CN1575801A Crocodile embryo extract |
| 02/09/2005 | CN1188517C Method of purifying thrombin-like protease enzymes obtained from snake venom |
| 02/09/2005 | CN1188508C Chinese herbal medicine tonic wine and its making process |
| 02/09/2005 | CN1188171C Method of preventing aggregation of various substances upon rehydration or thawing and compositions obtained thereby |
| 02/09/2005 | CN1188161C Medicines for treating cervical vertebra illness |
| 02/09/2005 | CN1188159C Medicines composition for treating coronary heart disease ventricular premature beat and its prepn |
| 02/09/2005 | CN1188158C Medicines composition for raising body's immunity and its prepn |
| 02/09/2005 | CN1188157C Chinese herbal medicine tumor-eliminating drop |
| 02/09/2005 | CN1188156C Medicine for treating apoplexia hemiplegia |
| 02/09/2005 | CN1188155C Bear gall pill of benefiting the liver |
| 02/09/2005 | CN1188153C Medicines for treating cancers and tumours |
| 02/09/2005 | CN1188149C Traditional Chinese medicine powder with functions of activating channels, relieving pain, dispelling wind-evil and strengthening-bone |
| 02/09/2005 | CN1188148C Process for preparing staltic-antagic medicine to treat trauma |
| 02/09/2005 | CN1188147C Bone Bi-syndrome treating pill |
| 02/09/2005 | CN1188145C Medicine for curing tuberculosis and preparing method |
| 02/09/2005 | CN1188143C Cold treating medicine |
| 02/09/2005 | CN1188140C Reduction of oxidative stress factors |
| 02/09/2005 | CN1188139C Bee glue purifying technological process |
| 02/09/2005 | CN1188138C Use of refind fur-seal oil in medicine for preventing and treating climacteric metancholia and menalgia |
| 02/09/2005 | CN1188055C Composition |